title: Pulmonary eosinophilia caused by testosterone cypionate.
authors.affiliation: Servicio de Neumología, Hospital Clínico Universitario de Valencia, Valencia, España. Electronic address: emonclou@hotmail.com.
authors.forename: Erick
authors.initials: E
authors.lastname: Monclou Garzón
authors.forename: Francisco
authors.initials: F
authors.lastname: Carrión Valero
authors.forename: Andrea
authors.initials: A
authors.lastname: Urbano Salcedo
mesh_terms: D000328:Adult; D056809:Alveolar Epithelial Cells / Q000648:ultrastructure; D045930:Anabolic Agents / Q000009:adverse effects*; D058633:Antipyretics / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D003951:Diagnostic Errors; D019587:Dietary Supplements / Q000009:adverse effects*; D004417:Dyspnea / Q000209:etiology; D006469:Hemoptysis / Q000209:etiology; D006801:Humans; D006965:Hyperplasia; D064704:Levofloxacin / Q000627:therapeutic use; D008297:Male; D010102:Oxygen Inhalation Therapy; D058573:Performance-Enhancing Substances / Q000009:adverse effects*; D011014:Pneumonia / Q000175:diagnosis; D011657:Pulmonary Eosinophilia / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D013739:Testosterone / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D045930:Anabolic Agents; D058633:Antipyretics; D058573:Performance-Enhancing Substances; D013739:Testosterone; D064704:Levofloxacin; C016131:testosterone 17 beta-cypionate